Zelmac Chiesa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Nektar Therapeutics (NASDAQ: NKTR) today announced that its partner Eli Lilly & Company presented preliminary results from a Lilly-sponsored.

United statesAndhra pradeshSan franciscoDan budwickZelmac chiesaVivian wuJonathan zalevskyEli lillyInvestment community meetingEli lilly companyExchange commission onNektar therapeuticsCollege of rheumatology meetingResearch developmentLilly sponsored phaseInvestment community